Figure 4.
Kaplan-Meier curves for (A) PFS and (B) OS are shown for patients according to their T790M mutation status, as detected by allele-specific competitive blocker-amplification refractory mutation system TaqMan quantitative polymerase chain reaction method in pre-tyrosine kinase inhibitor treatment samples. PFS, progression-free survival; OS, overall survival; CI, confidence interval.